The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and the ensuing global pandemic has presented a health emergency of unprecedented …

Abstract Severe Acute Respiratory Syndrome–Coronavirus-2 is responsible for the current
pandemic that has led to more than 10 million confirmed cases of Coronavirus Disease-19 …

Coagulopathy commonly occurs in sepsis as a critical host response to infection that can
progress to disseminated intravascular coagulation (DIC) with an increased mortality …

Background Microvascular, arterial and venous thrombotic events have been largely
described during severe coronavirus disease 19 (COVID-19). However, mechanisms …

Purpose Vitamin C has shown benefits in patients with sepsis in addition to standard therapy
recently. However, further evidence is required to verify the efficacy of vitamin C in clinical …

We aimed to investigate association between mean platelet volume (MVP), platelet
distribution width (PDW) and red cell distribution width (RDW) and mortality in patients with …

Patients with severe infections and a pre-existing indication for antithrombotic therapy, ie
antiplatelet agents, anticoagulant drugs, or their combinations, require integrated clinical …

The growing number of deaths related to sepsis has become a major concern for past few
years. Sepsis is a complex pathological reactions that is explained by series of host …

Abstract Coronavirus disease 2019 (COVID-19) is a pandemic syndrome caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. SARS-CoV-2 infection …

Background Patients with coronavirus disease 2019 (COVID-19) exhibit high thrombotic risk.
The evidence on a potential independent prognostic role of antiplatelet treatment in those …